ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Animal Reproduction - Theriogenology

Volume 12 - 2025 | doi: 10.3389/fvets.2025.1596006

In vitro maturation of Nelore breed (Bos taurus indicus) oocytes using either purified porcine FSH (pFSH) or recombinant human FSH (rhFSH): results from a large-scale in vitro embryo production routine

Provisionally accepted
Leticia  Prates MartinsLeticia Prates Martins1Luany  Alves Galvao MartinhaoLuany Alves Galvao Martinhao1Joao  Gabriel Viana GraziaJoao Gabriel Viana Grazia2Otavio  Augusto Costa FariaOtavio Augusto Costa Faria1Ricardo  Alamino FigueiredoRicardo Alamino Figueiredo3Joao  Henrique Moreira VianaJoao Henrique Moreira Viana1,3*
  • 1University of Brasilia, Brasilia, Distrito Federal, Brazil
  • 2FIVX Apoyar Biotech, Juiz de Fora, Brazil
  • 3Brazilian Agricultural Research Corporation (EMBRAPA), Brasília, Brazil

The final, formatted version of the article will be published soon.

This study evaluated whether porcine FSH (pFSH) could be replaced by follitropin-alpha, a recombinant human FSH (rhFSH), during in vitro maturation (IVM) of cumulus-oocyte complexes (COC) recovered from Nelore (Bos taurus indicus) cattle in a large-scale in vitro embryo production (IVP) program. We performed three experiments, all using grade I COC (n=10,208) submitted to IVM in TCM199 without FSH (-FSH, negative control) or supplemented with either 0.5 μg/mL pFSH (Folltropin-V) or 0.1 IU rhFSH (Gonal-F). The remaining procedures, media, and culture conditions for in vitro embryo production (IVP) were similar. In Exp. 1, COC (n=2,791) were IVM in the absence of FSH (-FSH) or with pFSH or rhFSH, and underwent IVP. Blastocysts were assessed for hatching as fresh or after vitrification and warming. Blastocyst rates were greater (P<0.05) in groups treated with than without FSH (39.3% and 40.6% vs 34.8% for pFSH, rhFSH and -FSH, respectively; P=0.0244). However, there was no effect of treatment on hatching rates of fresh (74.5%, 79.0% and 70.1% for -FSH, pFSH, and rhFSH, respectively; P=0.2621) or vitrified blastocysts (75.0%, 69.6% and 73.2% for -FSH, pFSH, and rhFSH, respectively; P=0.7623). In Exp.2, COC (n=720) were IVM in groups -FSH, pFSH, or rhFSH, and the expanded blastocysts produced were stained with Hoechst 33342 and propidium iodide. Blastocysts from the rhFSH group presented more cells in the trophoblast (110.3±5.6 vs 80.0±5.7 and 878.4±5.1 for rhFSH, -FSH, and pFSH, respectively; P=0.0002), but not in the ICM (P=0.3231), when compared with pFSH and -FSH groups. In Exp. 3, we used the same experimental design as in Exp. 1 but in a commercial IVP routine, which included the use of COC (n=6,697) recovered both by OPU and from slaughterhouse, Y-sorted semen, and the transfer of part of the blastocysts produced. Both pFSH and rhFSH increased cleavage (76.0% and 75.1% vs 71.6%, P=0.0035) and blastocyst rates (38.1% and 39.5% vs 34.3%, P=0.0102), but not pregnancy rate (43.8% and 33.3% vs 56.0%, P=0.1080), compared with -FSH. In summary, follitropin-alpha is an alternative to pFSH as a medium supplement for IVM of bovine COC.

Keywords: Cattle, Gonadotropins, In vitro maturation, Cumulus-oocyte complexes, Recombinant hormones

Received: 19 Mar 2025; Accepted: 12 Jun 2025.

Copyright: © 2025 Martins, Martinhao, Grazia, Faria, Alamino Figueiredo and Viana. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Joao Henrique Moreira Viana, Brazilian Agricultural Research Corporation (EMBRAPA), Brasília, Brazil

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.